AVDL
Avadel Pharmaceuticals PLC
NASDAQ: AVDL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$21.64
+0.00% today
Updated 2026-02-12
Market cap
$2.12B
P/E ratio
0.00
P/S ratio
8.55x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$6 – $24
Volume
2.2M
Avadel Pharmaceuticals PLC (AVDL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-0.00%
Operating margin
0.03%
ROE
-0.00%
ROA
-0.00%
Debt/equity
0.38x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2005 | $23.60M | $-27.38M | 89.30% | -172.76% | -116.01% |
| 2006 | $23.02M | $-35.20M | 72.85% | -168.71% | -152.91% |
| 2007 | $36.65M | $-37.74M | 52.75% | -111.44% | -102.95% |
| 2008 | $38.62M | $-12.08M | 75.09% | -52.20% | -31.29% |
| 2009 | $42.12M | $-11.44M | 75.98% | -27.90% | -27.16% |
| 2010 | $37.09M | $-8.97M | 81.36% | -26.53% | -24.20% |
| 2011 | $32.60M | $-8.77M | 80.72% | -29.40% | -26.91% |
| 2012 | $26.10M | $-3.23M | 77.55% | -13.36% | -12.37% |
| 2013 | $22.44M | $-42.92M | 80.62% | -222.93% | -191.26% |
| 2014 | $14.78M | $-84.91M | 77.10% | -635.24% | -574.66% |
| 2015 | $173.21M | $40.66M | 93.69% | 41.25% | 23.47% |
| 2016 | $150.25M | $-41.28M | 91.18% | -3.30% | -27.47% |
| 2017 | $172.74M | $67.25M | 90.56% | 51.12% | 38.93% |
| 2018 | $103.27M | $-95.30M | 83.04% | -101.60% | -92.29% |
| 2019 | $59.22M | $-33.23M | 79.52% | -40.72% | -56.11% |
| 2020 | $22.33M | $7.03M | 74.29% | 26.04% | 31.47% |
| 2021 | $0.00 | $-77.33M | — | — | — |
| 2022 | $1.50M | $-137.46M | -99.80% | -6,588.30% | -9,188.77% |
| 2023 | $27.96M | $-160.28M | 96.97% | -492.97% | -573.17% |
| 2024 | $169.12M | $-48.83M | 90.97% | -25.07% | -28.87% |